Clinical and laboratory studies on treating chronic active hepatitis with Inj. Radix Astragali
Li Qiangzhong,Huang Chengjun,Jiao Lihua, Pan Shijun (People's Hospital of Hangting District,Weifang City,Shandong,Weifang 261100)
The aim of this article is to determine the efficacy and practical value of Inj. Radix Astragali in the treatment of chronic active hepatitis(CAH). 121 patients with CAH were allocated randomly into treatment and control groups. The patients in the treatment group received Inj. Radix Astragali intramuscularly bid and patients in control group received Chui-Peng-Cao granules orally tid. The duration of a course of treatment is 2 months in both groups. The result showed that the improvement in signs and symptoms did not differ significantly between 2 groups(P0. 05). However,the global response rate and HBeA seroconversion rate in the treatment group were significantly higher than those in the control group(P0. 01 ,respectively). IgG and complement C levels decreased significanlly in the treatment group. The results suggeste that Inj. Radix Astragali not only enhanced the recovery of liver cell functions but also improved cellular and humoral immunization of the individuals.
【CateGory Index】： R575.1